Background Targeting immunotherapy has become a novel strategy in psoriatic therapy.Anticytokine antibodies of the key cytokines IL-23,TNF,and IL-17 have achieved great success in psoriatic treatment.IL-33,a newly found member of the IL-1 family,significantly increased in lesional and non-lesional skin of psoriatic patient compared with healthy skin.